RSPO3 and Hepatic fibrosis: Deletion of Rspo3 in HSCs or inhibition of RSPO3 by blocking antibodies51 inhibited CCl4-induced fibrosis in mice, but P450-activated toxins like APAP are not considered clinically relevant causes of CLD and liver fibrosis as they usually trigger only acute liver disease.